154 related articles for article (PubMed ID: 14719104)
1. Expression of CD97 and CD55 in human medullary thyroid carcinomas.
Mustafa T; Klonisch T; Hombach-Klonisch S; Kehlen A; Schmutzler C; Koehrle J; Gimm O; Dralle H; Hoang-Vu C
Int J Oncol; 2004 Feb; 24(2):285-94. PubMed ID: 14719104
[TBL] [Abstract][Full Text] [Related]
2. Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas.
Mustafa T; Eckert A; Klonisch T; Kehlen A; Maurer P; Klintschar M; Erhuma M; Zschoyan R; Gimm O; Dralle H; Schubert J; Hoang-Vu C
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):108-19. PubMed ID: 15668483
[TBL] [Abstract][Full Text] [Related]
3. The expression of CD97EGF and its ligand CD55 on marginal epithelium is related to higher stage and depth of tumor invasion of gastric carcinomas.
Liu Y; Chen L; Peng S; Chen Z; Gimm O; Finke R; Hoang-Vu C
Oncol Rep; 2005 Dec; 14(6):1413-20. PubMed ID: 16273233
[TBL] [Abstract][Full Text] [Related]
4. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.
Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ
J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446
[TBL] [Abstract][Full Text] [Related]
5. Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients.
Liu Y; Chen L; Peng SY; Chen ZX; Hoang-Vu C
J Zhejiang Univ Sci B; 2005 Sep; 6(9):913-8. PubMed ID: 16130195
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma.
Wu J; Lei L; Wang S; Gu D; Zhang J
J Biomed Biotechnol; 2012; 2012():587672. PubMed ID: 22547928
[TBL] [Abstract][Full Text] [Related]
7. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF).
Hamann J; Vogel B; van Schijndel GM; van Lier RA
J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution of the human CD97 EGF-TM7 receptor.
Jaspars LH; Vos W; Aust G; Van Lier RA; Hamann J
Tissue Antigens; 2001 Apr; 57(4):325-31. PubMed ID: 11380941
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97.
Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA
Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
Qian YM; Haino M; Kelly K; Song WC
Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
[TBL] [Abstract][Full Text] [Related]
11. Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue.
Hamann J; Wishaupt JO; van Lier RA; Smeets TJ; Breedveld FC; Tak PP
Arthritis Rheum; 1999 Apr; 42(4):650-8. PubMed ID: 10211878
[TBL] [Abstract][Full Text] [Related]
12. Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness.
Brandt B; Mikesch JH; Simon R; Rötger A; Kemming D; Schier K; Sauter G; Bürger H
Biochem Biophys Res Commun; 2005 Apr; 329(1):318-23. PubMed ID: 15721309
[TBL] [Abstract][Full Text] [Related]
13. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding.
Wobus M; Vogel B; Schmücking E; Hamann J; Aust G
Int J Cancer; 2004 Dec; 112(5):815-22. PubMed ID: 15386373
[TBL] [Abstract][Full Text] [Related]
14. CD97: a dedifferentiation marker in human thyroid carcinomas.
Aust G; Eichler W; Laue S; Lehmann I; Heldin NE; Lotz O; Scherbaum WA; Dralle H; Hoang-Vu C
Cancer Res; 1997 May; 57(9):1798-806. PubMed ID: 9135025
[TBL] [Abstract][Full Text] [Related]
15. Analysis of membrane-bound complement regulatory proteins in prostate cancer.
Loberg RD; Wojno KJ; Day LL; Pienta KJ
Urology; 2005 Dec; 66(6):1321-6. PubMed ID: 16360477
[TBL] [Abstract][Full Text] [Related]
16. Human EMR2, a novel EGF-TM7 molecule on chromosome 19p13.1, is closely related to CD97.
Lin HH; Stacey M; Hamann J; Gordon S; McKnight AJ
Genomics; 2000 Jul; 67(2):188-200. PubMed ID: 10903844
[TBL] [Abstract][Full Text] [Related]
17. CD97, but not its closely related EGF-TM7 family member EMR2, is expressed on gastric, pancreatic, and esophageal carcinomas.
Aust G; Steinert M; Schütz A; Boltze C; Wahlbuhl M; Hamann J; Wobus M
Am J Clin Pathol; 2002 Nov; 118(5):699-707. PubMed ID: 12428789
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55.
Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM
J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CD97 protein in thyroid carcinoma.
Hoang-Vu C; Bull K; Schwarz I; Krause G; Schmutzler C; Aust G; Köhrle J; Dralle H
J Clin Endocrinol Metab; 1999 Mar; 84(3):1104-9. PubMed ID: 10084602
[TBL] [Abstract][Full Text] [Related]
20. Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue.
Kop EN; Kwakkenbos MJ; Teske GJ; Kraan MC; Smeets TJ; Stacey M; Lin HH; Tak PP; Hamann J
Arthritis Rheum; 2005 Feb; 52(2):442-50. PubMed ID: 15693006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]